ArticleCureus2025
Zinc-Induced Copper Deficiency Myeloneuropathy Masquerading as Paraneoplastic Syndrome: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Metallic Contaminants and Osteoporosis: a Review of the Gut-Bone Axis.Biological trace element research · 2026Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Copper deficiency is a rare but reversible cause of myeloneuropathy, often overlooked in patients presenting with progressive neurological deficits. Excessive zinc intake, particularly from denture adhesives, can lead to copper depletion through competitive inhibition of intestinal absorption. We present the case of a 63-year-old female with a history of chronic obstructive pulmonary disease (COPD), Stage IIIA triple-negative breast cancer (TNBC) (status post mastectomy with adjuvant therapy), peripheral neuropathy, and a prior cecal adenoma who was admitted for hematochezia and progressive generalized weakness over several weeks. Imaging revealed a suspicious 1.4 cm pulmonary nodule in the left lower lobe and a 2.6 cm x 1.8 cm x 1.5 cm destructive lytic lesion in the left parietal bone. Given her worsening lower extremity weakness, concern for a paraneoplastic syndrome prompted a lumbar puncture and paraneoplastic antibody panel, both of which were negative. The patient underwent a five-day course of intravenous immunoglobulin (IVIG) without improvement. Further metabolic workup revealed profound copper deficiency of 417 µg/L (reference range: 810-1,990 µg/L). Upon further questioning, the patient reported chronic use of zinc-containing denture adhesive. She was initiated on copper supplementation with significant neurological improvement over several months, transitioning from being wheelchair bound to ambulating with a walker. Pathology from resection of the skull lesion revealed a World Health Organization (WHO) grade 1 meningioma, while the lung lesion was treated with CyberKnife, confirming Stage IA squamous cell carcinoma. This case highlights the importance of considering nutritional deficiencies in patients with symptoms of progressive myeloneuropathy, such as gait disturbances, sensory ataxia, or spasticity, particularly in those with risk factors such as chronic denture adhesive use. Clinicians should maintain a high index of suspicion for copper deficiency in cases mimicking paraneoplastic syndromes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.